Re:FDA Warning Letter to 23andMe
by aroch on Monday November 25, 2013 @11:01AM
(#6794768)
23&me isn't particularly innovative...They just took existing genotyping and made it available to everyone in pretty graphs
[ Parent
| on HN ]
Care to share a link to a competitor?
Any hospital offering primary care has a lab at their disposal that can do this. Genotyping is nothing new...but as for competitors in 23&me's area (aka public access genotyping for cheap an that I can remember off the top of my head): deCODEme, lumigenix, Dna Genotek and MapMyGenome
Re:FDA Warning Letter to 23andMe
by dragonwriter on Monday November 25, 2013 @01:26PM
(#6795825)
Navigenics, with Navigenics Health Compass, was a competitor to 23andMe with their PGS offering, but Navigenics appears to have discontinued the competing offering (Navigenics was received initial contact from the FDA at about their product at the same time 23andMe did, they also went through similar rounds with the State of California for licensing to operate their before that.)
There's a number of other offerings that have been made in the same general space, as well.